Harmony Biosciences to Participate in Upcoming Investor Conferences

News > Health News

Audio By Carbonatix

8:05 AM on Wednesday, March 4

The Associated Press

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Mar 4, 2026--

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will attend the following upcoming investor conferences.

Leerink Partners Global Healthcare Conference

Date: March 9, 2026
Location: Miami, FL

UBS Biotech Summit

Date: March 9, 2026
Location: Miami, FL

Barclays 28th Annual Global Healthcare Conference

Date: March 10, 2026
Location: Miami, FL

About Harmony Biosciences

Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa., we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260304620056/en/

CONTACT: Harmony Biosciences Investor Contact:

Matthew Beck

917-415-1750

[email protected]

Harmony Biosciences Media Contact:

Cate McCanless

202-641-6086

[email protected]

KEYWORD: FLORIDA PENNSYLVANIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH NEUROLOGY CLINICAL TRIALS GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Harmony Biosciences Holdings, Inc.